F2RL1 and Alzheimer disease: These and other data raise the question of whether the keratinocyte-protease-PAR2 system may mediate barrier defects, sensory signaling and neuro-immune communication in human AD, and whether PAR2 antagonists and/or selective protease inhibitors may be a novel approach for its treatment.